Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Purchases an Agilent 6545XT AdvanceBio Q-TOF Mass Spectrometer and a Malvern Panalytical Empyrean X-Ray Powder Diffractometer.
January 16, 2025
By: Kristin Brooks
Managing Editor, Contract Pharma
Almac Sciences, a member of the Almac Group, has invested £500,000 in state-of-the-art instrumentation within its spectroscopy labs at its global headquarters in Craigavon, Northern Ireland.
Almac has purchased the new Agilent 6545XT AdvanceBio Q-TOF Mass Spectrometer and a Malvern Panalytical Empyrean X-Ray Powder Diffractometer.
The Craigavon labs house state-of-the-art Mass Spectrometers, X-Ray Powder Diffractometers as well as Nuclear Magnetic Resonance Spectrometers. These investments substantially increase the company’s capabilities to help solve complex analytical challenges and provide additional security for urgent analyses, additional processing capabilities, and data integrity controls to ensure increasing regulatory compliance.
Within the dedicated facility, equipped with advanced LC-MS, GC-MS, ICP-MS, XRPD and NMR instrumentation, spectrometry services include the quantitation of genotoxic impurities, trace elemental analysis, isotopic purity determinations, structure elucidation, analysis of peptides, proteins, glycoproteins and antibody products as well as polymorph screening, confirmation and quantitation of crystalline phases.
Dr. John Malone, Associate Director of Spectroscopy, Almac Sciences said, “The continued investment and growth in our spectroscopy laboratories underlines Almac’s commitment to providing the best analytical facilities for its customers and seamlessly meeting their needs. We are delighted to offer our clients cutting-edge technology that supports their product safety imperative and accelerates the drug development cycle.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !